Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AMNEAL

  • FDA Approval
  • Sept. 04, 2025, 09:00 UTC
  • 7
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

AJANTA PHARMA LTD

  • FDA Approval
  • Sept. 04, 2025, 09:00 UTC
  • 9
  • 0 comments

FDA approve TOPIRAMATE

Comment Full text

AC Immune Ltd (ACIU)

  • Business News
  • Sept. 04, 2025, 07:45 UTC
  • 5
  • 0 comments

AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway

Market reaction Comment Full text

Plus Therapeutics Inc (PSTV)

  • Business News
  • Sept. 04, 2025, 07:33 UTC
  • 5
  • 0 comments

Now Available: Recording of LM Symposium from SNO/ASCO CNS Metastases Conference

Market reaction Comment Full text

Portage Biotech Inc. (PRTG)

  • Technical Exchange News
  • Sept. 04, 2025, 07:27 UTC
  • 6
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: D. New value: Portage Biotech Inc. - Common Stock.

Comment Full text

Portage Biotech Inc. (PRTG)

  • Technical Exchange News
  • Sept. 04, 2025, 07:27 UTC
  • 6
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Portage Biotech Inc. - Common Stock. New value: Portage Biotech Inc. - Common Stock.

Comment Full text

COSCIENS Biopharma Inc. (CSCI)

  • Technical Exchange News
  • Sept. 04, 2025, 07:27 UTC
  • 5
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: COSCIENS Biopharma Inc. - Common Stock.

Comment Full text

COSCIENS Biopharma Inc. (CSCI)

  • Technical Exchange News
  • Sept. 04, 2025, 07:27 UTC
  • 6
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: COSCIENS Biopharma Inc. - Common Stock.

Comment Full text

Portage Biotech Inc. (PRTG)

  • Technical Exchange News
  • Sept. 04, 2025, 07:27 UTC
  • 4
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Portage Biotech Inc. - Common Stock.

Comment Full text

Immunoprecise Antibodies Ltd (IPA)

  • Technical Exchange News
  • Sept. 04, 2025, 07:27 UTC
  • 6
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: ImmunoPrecise Antibodies Ltd. - Common Stock. New value: ImmunoPrecise Antibodies Ltd. - Common Stock.

Comment Full text

Immunoprecise Antibodies Ltd (IPA)

  • Technical Exchange News
  • Sept. 04, 2025, 07:27 UTC
  • 7
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: ImmunoPrecise Antibodies Ltd. - Common Stock.

Comment Full text

COSCIENS Biopharma Inc. (CSCI)

  • Technical Exchange News
  • Sept. 04, 2025, 07:27 UTC
  • 6
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: COSCIENS Biopharma Inc. - Common Stock. New value: COSCIENS Biopharma Inc. - Common Stock.

Comment Full text

Immunoprecise Antibodies Ltd (IPA)

  • Technical Exchange News
  • Sept. 04, 2025, 07:27 UTC
  • 6
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: ImmunoPrecise Antibodies Ltd. - Common Stock.

Comment Full text

Immunoprecise Antibodies Ltd (IPA)

  • Technical Exchange News
  • Sept. 04, 2025, 07:25 UTC
  • 7
  • 0 comments

Immunoprecise Antibodies Ltd (IPA) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Portage Biotech Inc. (PRTG)

  • Technical Exchange News
  • Sept. 04, 2025, 07:25 UTC
  • 6
  • 0 comments

Portage Biotech Inc. (PRTG) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text
  • Previous
  • 247
  • 248
  • 249
  • 250
  • 251
  • Next

Search

News categories

  • Technical Exchange News(10076)
  • Event(415)
  • SEC News(170479)
  • FDA Approval(9464)
  • Company Report(721)
  • Business News(113550)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin